课题基金 / 基金详情

Nanoprobes for Molecule-Specific Contrast Enhancement

Nanoprobes for Molecule-Specific Contrast Enhancement
用于分子特异性对比度增强的纳米探针
批准号:
6551178
负责人:
LEYUN ZHU
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-02 至 2003-03-01

项目摘要

项目成果

LEYUN ZHU的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):建议开发纳米拉曼探测器,以便于检测单个分子的拉曼散射。拟议的第一阶段研究将侧重于纳米颗粒系统和分析物-纳米颗粒复合体的合理设计。纳米颗粒-固态支撑平台也将在拟议的研究中进行优化。在第一阶段的研究中,将建立一种分析复杂细胞系统中单分子振动光谱的策略的可行性。这项研究将导致开发一种具有分析单个分子结构能力的市场分析系统。我们相信,一个强大灵敏的拉曼系统的可用性将引起化学和生物医学研究人员的广泛兴趣。它可能会对DNA测序、早期疾病检测和环境监测产生影响。
英文摘要
DESCRIPTION (provided by applicant): Development of nano-Raman probes that will facilitate the detection of Raman scattering of individual molecule is proposed. The proposed phase I research will focus on the rational design of a nanoparticle system and analyte-nanoparticle complex. The nanoparticle-solid state support platform will also be optimized in the proposed research. During the phase I research the feasibility of a strategy for analyzing single molecule vibrational spectrum in complex cellular system will be established. This research will lead to the development of a marketable analytical system with the capability of analyzing the structure of an individual molecule. We believe that the availability of a robust sensitive Raman system will have broad interest from chemical and biomedical researchers. And it might have impact on DNA sequencing, early stage disease detection, and environmental monitoring.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative high throughput tunable filter for widefield biomedical Raman imaging
  • 批准号:
    8592656
  • 项目类别:
  • 资助金额:
    $24.62万
  • 财政年份:
    2013
  • 负责人:
    LEYUN ZHU
  • 依托单位:
Compact all-fiber based CARS microscope for biomedical imaging
  • 批准号:
    8314945
  • 项目类别:
  • 资助金额:
    $11.56万
  • 财政年份:
    2012
  • 负责人:
    LEYUN ZHU
  • 依托单位:
Novel Raman Method for Molecular Analysis of Tissue
  • 批准号:
    6689035
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2003
  • 负责人:
    LEYUN ZHU
  • 依托单位:
ULTRAFAST STUDIES OF BACTERIORHODOPSIN AND RHODOPSIN
海外基金